Similar articles

• Acute hepatic failure associated with the use of sodium valproate.

  Suchy FJ, Balistreri WF, Buchino JJ, Sondheimer JM, Bates SR, Kearns GL, Stull JD, Bove KE. Suchy FJ, et al. N Engl J Med. 1979 Apr 26;300(17):962-6. doi: 10.1056/NEJM197904263001706. N Engl J Med. 1979. PMID: 372803 No abstract available.
• Fatal liver failure in children on valproate.

  Scheffner D. Scheffner D. Lancet. 1986 Aug 30;2(8505):511. doi: 10.1016/s0140-6736(86)90376-4. Lancet. 1986. PMID: 2875255 No abstract available.
• Sodium valproate and routine liver function tests.

  Green SH. Green SH. Arch Dis Child. 1984 Sep;59(9):813-4. doi: 10.1136/adc.59.9.813. Arch Dis Child. 1984. PMID: 6435543 Free PMC article. No abstract available.
• Valproate toxicity: risk-screening strategies.

  Willmore LJ, Triggs WJ, Pellock JM. Willmore LJ, et al. J Child Neurol. 1991 Jan;6(1):3-6. doi: 10.1177/088307389100600101. J Child Neurol. 1991. PMID: 2002198 Review. No abstract available.
• [Valproate dosage].

  Meyer FP, Walther H. Meyer FP, et al. Psychiatr Neurol Med Psychol (Leipz). 1989 Mar;41(3):134-43. Psychiatr Neurol Med Psychol (Leipz). 1989. PMID: 2498918 Review. German.